Alexander von Gabain
Overview
Explore the profile of Alexander von Gabain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
854
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alkan S, Decker T, von Gabain A
Vaccine
. 2012 Apr;
30(29):4299-300.
PMID: 22464968
No abstract available.
2.
Klade C, Schuller E, Boehm T, von Gabain A, Manns M
Vaccine
. 2012 Mar;
30(19):2943-50.
PMID: 22401867
Background: Novel antivirals augment treatment efficacy in chronic HCV infection, to overcome limitations on safety profile alternative approaches are warranted. The effect of a therapeutic peptide vaccine on HCV viral...
3.
4.
Senn B, Visram Z, Meinke A, Neubauer C, Gelbmann D, Sinzinger J, et al.
Vaccine
. 2011 Apr;
29(24):4116-24.
PMID: 21496467
Group B streptococcus remains an important neonatal pathogen in spite of widely adopted intrapartum antibiotic administration; therefore immune prophylaxis for GBS infections is highly warranted. In passive immunization and lethal...
5.
Aichinger M, Ginzler M, Weghuber J, Zimmermann L, Riedl K, Schutz G, et al.
Vaccine
. 2010 Nov;
29(3):426-36.
PMID: 21093498
IC31(®) is a novel bi-component vaccine adjuvant consisting of the peptide KLKL(5)KLK (KLK) and the TLR9 agonist oligonucleotide d(IC)(13) (ODN1a). While membrane-interacting properties of KLK and immuno-modulating capabilities of ODN1a...
6.
Meinke A, Senn B, Visram Z, Henics T, Bui Minh D, Schuler W, et al.
Vaccine
. 2010 Aug;
28(43):6997-7008.
PMID: 20732466
Group B streptococcus is one of the most important pathogens in neonates, and causes invasive infections in non-pregnant adults with underlying diseases. Applying a genomic approach that relies on human...
7.
Fritzer A, Senn B, Bui Minh D, Hanner M, Gelbmann D, Noiges B, et al.
Infect Immun
. 2010 Jul;
78(9):4051-67.
PMID: 20624906
Group A streptococci (GAS) can cause a wide variety of human infections ranging from asymptomatic colonization to life-threatening invasive diseases. Although antibiotic treatment is very effective, when left untreated, Streptococcus...
8.
von Gabain A
Hum Vaccin
. 2010 Apr;
6(2):164-8.
PMID: 20424513
Born 1950 in the small town of Coburg in post-war West Germany, I was surrounded by a strange mindset that was coded by a "Gemisch" of "Verdrängung" of the country's...
9.
Giefing C, Nagy E, von Gabain A
Adv Exp Med Biol
. 2010 Jan;
655:90-117.
PMID: 20047038
New strategies are needed to master infectious diseases. The so-called "passive vaccination", i.e., prevention and treatment with specific antibodies, has a proven record and potential in the management of infections...
10.
Prchal M, Pilz A, Simma O, Lingnau K, von Gabain A, Strobl B, et al.
Vaccine
. 2009 Dec;
27 Suppl 6:G17-20.
PMID: 20006134
Originally identified as antiviral substances produced by infected cells, type I interferons (IFN-I) are now known to have a wide range of additional activities within both the innate and adaptive...